Screening, imaging, AMR discovery policy

AMR screening facility HG2/3 https://warwick.ac.uk/fac/cross_fac/amrscreening/

Cross scale research capabilities from atomic to whole cell
https://warwick.ac.uk/fac/cross_fac/howard-dalton-centre/about/

Technology:
  • Antimicrobial compound/strategy
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Fungi
  • Parasites
  • Viruses
  • Yeasts

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Academia
  • Company
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


Academic, SME, global pharma

University

Leadership in Enhancing Antimicrobial Discovery (LEAD)
UK Japan collaboration a template for wider global consortia to train the next generation
https://warwick.ac.uk/newsandevents/pressreleases/?newsItem=8a1785d790977dd0019097dc97dc014b


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed